av/cincor-pharma--big.svg

NASDAQ:CINC

CinCor Pharma, Inc.

  • Stock

USD

Last Close

29.06

23/02 21:00

Market Cap

1.27B

Beta: -

PE Ratio

−19.81

PFCF: −24.25

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
revenue
cost of revenue
gross profit
selling and marketing expenses
general and administrative expenses
1.21M
-
3.17M
162.12%
21.00M
561.67%
selling general and administrative expenses
1.21M
-
3.17M
162.12%
21.00M
561.67%
research and development expenses
3.93M
-
17.95M
357.24%
21.51M
19.84%
other expenses
cost and expenses
5.14M
-
21.13M
311.26%
42.51M
101.23%
operating expenses
5.14M
-
21.13M
311.26%
42.51M
101.23%
interest expense
ebitda
-5.14M
-
-19.92M
287.70%
-34.63M
73.88%
operating income
-5.14M
-
-21.13M
311.26%
-42.51M
101.23%
depreciation and amortization
1.21M
-
7.88M
551.36%
total other income expenses net
101.71K
-
-1.17M
1,253.42%
-7.86M
569.91%
income before tax
-5.04M
-
-22.30M
342.86%
-50.37M
125.89%
income tax expense
-101.71K
-
-36.73K
63.89%
-21.64K
41.08%
net income
-4.93M
-
-22.26M
351.25%
-50.35M
126.16%
weighted average shs out
23.49M
-
23.49M
0%
35.42M
50.76%
weighted average shs out dil
23.49M
-
23.49M
0%
35.42M
50.76%
eps
-0.21
-
-0.95
352.38%
-1.42
49.47%
epsdiluted
-0.21
-
-0.95
352.38%
-1.42
49.47%

All numbers in USD (except ratios and percentages)